Eurofins Scientific SE (ERF)
Euronext
79.00
+0.06 (+0.08%)
Closed
Oct 20, 2026
Day's Range
77.9679.38
52 wk Range
54.8679.38
Financial Statements - ERF - Eurofins Scientific SE
Revenue
7.29B▲ 5.0%
Net Income
473.00M▲ 16.6%Net Margin 6.5%
EBITDA
1.57B▲ 9.2%
Free Cash Flow
564.10M▼ 28.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 7.29B | 6.95B | 6.51B | 6.71B | 6.71B | 5.43B |
| Cost of Goods | 2.32B | 2.23B | 2.15B | 2.22B | 2.14B | 1.74B |
| Gross Profit | 4.97B | 4.71B | 4.36B | 4.48B | 4.56B | 3.69B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 818.30M | 726.20M | 546.80M | 783.20M | 1.27B | 805.50M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 654.10M | 554.60M | 423.30M | 780M | 1.05B | 694.40M |
| Income Tax | 181.10M | 149.10M | 115.50M | 174.20M | 273.60M | 153.90M |
| Net Income | 473M | 405.50M | 307.80M | 605.80M | 783M | 540.50M |
| EPS Basic | 2.64 | 2.13 | 1.61 | 3.17 | 4.09 | 2.9 |
| EPS Diluted | 2.55 | 2.09 | 1.57 | 3.07 | 3.9 | 2.75 |
| Basic Shares Outstanding | 179.80M | 190.60M | 192.90M | 192.50M | 191.50M | 186.20M |
| Diluted Shares Outstanding | 179.80M | 190.60M | 192.90M | 192.50M | 191.50M | 186.20M |
| Ebit | 811.20M | 705.40M | 552.70M | 885.60M | 1.15B | 798M |
| Ebitda | 1.57B | 1.44B | 1.23B | 1.36B | 1.71B | 1.33B |
| Net Income Continuous Operations | 654.10M | 554.60M | 423.30M | 780M | 1.05B | 694.40M |
| Minority Interests | 1.80M | 900K | 2.50M | 4.40M | -400K | -1M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
